Studies on antiviral resistant SARS-CoV-2 Mpro mutants

被引：0
|
作者：
Esler, Morgan A. [1 ]
Moghadasi, Arad [1 ]
Harris, Reuben S. [2 ]
Aihara, Hideki [1 ]
机构：
[1] Univ Minnesota, Biochem Mol Biol & Biophys, Minneapolis, MN USA
[2] Univ Texas San Antonio, Dept Biochem & Struct Biol, San Antonio, TX USA
来源：
BIOPHYSICAL JOURNAL | 2023年 / 122卷 / 03期
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
186-Pos
引用
收藏
页码：39A / 39A
页数：1
相关论文
共 50 条
  • [21] Binding of inhibitors to the monomeric and dimeric SARS-CoV-2 Mpro
    Tam, Nguyen Minh
    Nam, Pham Cam
    Quang, Duong Tuan
    Tung, Nguyen Thanh
    Vu, Van V.
    Ngo, Son Tung
    RSC ADVANCES, 2021, 11 (05) : 2926 - 2934
  • [22] Investigation of Thiocarbamates as Potential Inhibitors of the SARS-CoV-2 Mpro
    Papaj, Katarzyna
    Spychalska, Patrycja
    Hopko, Katarzyna
    Kapica, Patryk
    Fisher, Andre
    Lill, Markus A.
    Bagrowska, Weronika
    Nowak, Jakub
    Szleper, Katarzyna
    Smiesko, Martin
    Kasprzycka, Anna
    Gora, Artur
    PHARMACEUTICALS, 2021, 14 (11)
  • [23] Luminescent Assay for the Screening of SARS-CoV-2 MPro Inhibitors
    Sondag, Daan
    Merx, Jona
    Rossing, Emiel
    Boltje, Thomas J.
    Lowik, Dennis W. P. M.
    Nelissen, Frank H. T.
    van Geffen, Mark
    Veer, Cornelis van 't
    van Heerde, Waander L.
    Rutjes, Floris P. J. T.
    CHEMBIOCHEM, 2022, 23 (15)
  • [24] Structural biology of SARS-CoV-2 Mpro and drug discovery
    Duan, Yinkai
    Wang, Haofeng
    Yuan, Zhenghong
    Yang, Haitao
    CURRENT OPINION IN STRUCTURAL BIOLOGY, 2023, 82
  • [25] SARS-CoV-2 Mpro oligomerization as a potential target for therapy
    Lis, Kinga
    Plewka, Jacek
    Menezes, Filipe
    Bielecka, Ewa
    Chykunova, Yuliya
    Pustelny, Katarzyna
    Niebling, Stephan
    Garcia, Angelica Struve
    Garcia-Alai, Maria
    Popowicz, Grzegorz M.
    Czarna, Anna
    Kantyka, Tomasz
    Pyrc, Krzysztof
    International Journal of Biological Macromolecules, 2024, 267
  • [26] Advances in the Search for SARS-CoV-2 Mpro and PLpro Inhibitors
    Diogo, Marcel Arruda
    Cabral, Augusto Gomes Teixeira
    de Oliveira, Renata Barbosa
    PATHOGENS, 2024, 13 (10):
  • [27] Statine-based peptidomimetic compounds as inhibitors for SARS-CoV-2 main protease (SARS-CoV-2 Mpro)
    Azevedo, Pedro Henrique R. de A.
    Camargo, Priscila G.
    Constant, Larissa E. C.
    Costa, Stephany da S.
    Silva, Celimar Sinezia
    Rosa, Alice S.
    Souza, Daniel D. C.
    Tucci, Amanda R.
    Ferreira, Vivian N. S.
    Oliveira, Thamara Kelcya F.
    Borba, Nathalia R. R.
    Rodrigues, Carlos R.
    Albuquerque, Magaly G.
    Dias, Luiza R. S.
    Garrett, Rafael
    Miranda, Milene D.
    Allonso, Diego
    Lima, Camilo Henrique da S.
    Muri, Estela Maris F.
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [28] Selection, identification, and characterization of SARS-CoV-2 monoclonal antibody resistant mutants
    Oladunni, Fatai S.
    Park, Jun-Gyu
    Chiem, Kevin
    Ye, Chengjin
    Pipenbrink, Michael
    Walter, Mark R.
    Kobie, James
    Martinez-Sobrido, Luis
    JOURNAL OF VIROLOGICAL METHODS, 2021, 290
  • [29] Discovery and characterization of naturally occurring covalent inhibitors of SARS-CoV-2 Mpro from the antiviral herb Ephedra
    Qing, Hu
    Zhang, Yiwen
    Chen, Pengcheng
    Zhang, Yani
    Zhu, Guanghao
    Liu, Wei
    Wang, Chaoran
    Zheng, Shuilian
    Shen, Nonger
    Wang, Haonan
    Huang, Ping
    Ge, Guangbo
    CHINESE JOURNAL OF NATURAL MEDICINES, 2024, 22 (09) : 797 - 807
  • [30] Crystal structures of main protease (Mpro) mutants of SARS-CoV-2 variants bound to PF-07304814
    Haihai Jiang
    Xiaofang Zou
    Pei Zeng
    Xiangyi Zeng
    Xuelan Zhou
    Jie Wang
    Jin Zhang
    Jian Li
    Molecular Biomedicine, 4
12345